MedPath

Clinical Assessment of Visual Function With the Acrysof ReSTOR Multifocal IOL

Phase 4
Withdrawn
Conditions
Visual Outcomes
Interventions
Device: Acrysof ReSTOR multifocal IOL
Registration Number
NCT00758940
Lead Sponsor
Alcon Research
Brief Summary

An unmasked trial after bilateral implantation of AcrySof® ReSTOR®, SA60D3 IOL . Enrolled are at least 30 patients or as much as possible from the doctor's clinical practice perspective. 6 months follow-up after IOL implant in the 2nd eye

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Able to complete all required postoperative visits; Planned cataract removal by phaco; 21 years of age or older, either gender or any race; potential postoperative visual acuity of 20/20; astigmatism ≦1.0D measured by keratometry in study eye(s);clear int
Exclusion Criteria
  • Signs of capsular tear, significant anterior chamber hyphema;zonular rupture; corneal pathology and refractive surgery;hypercritical patient; patients with unrealistic expectations in post-op VA; happy to wear glasses;occupational night drivers

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Acrysof ReSTOR multifocal IOLAcrysof ReSTOR multifocal IOL
Primary Outcome Measures
NameTimeMethod
Near,intermediate,distance visual acuitypre-op;1 week after 1st eye surgery,1month and 6 month after 2nd eye surgery
Secondary Outcome Measures
NameTimeMethod
contrast sensitivity6 month after 2nd eye surgery

Trial Locations

Locations (1)

Alcon Call Center

🇺🇸

Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath